Loading clinical trials...
Loading clinical trials...
A Study to Evaluate the Performance, Usability, and Reliability of a Novel Device for Continuous Collection of Physiological Data in Healthcare and Remote Settings
Study objective: The primary objective of the clinical investigation is to evaluate the accuracy of BioStamp nPoint system algorithm measurements. Study design: A single-site, non-significant risk, open-label, prospective non-randomized clinical investigation designed to validate the accuracy of the various physiological parameters that the Wearable Sensor Patches acquire and the system processes.
Age
18 - 99 years
Sex
ALL
Healthy Volunteers
Yes
CTI Clinical Research Center
Cincinnati, Ohio, United States
Start Date
July 31, 2017
Primary Completion Date
August 25, 2017
Completion Date
August 30, 2017
Last Updated
January 25, 2019
30
ACTUAL participants
Physiological signal monitor
DEVICE
Heart rate and heart rate variability comparison device
DEVICE
Respiration rate comparison device
DEVICE
Activity classification
OTHER
Lead Sponsor
MC10 Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions